With the release of a Composable MES App Suite for Pharmaceuticals and enhanced features for governed software deployment, Tulip sets a new standard for human-centric, error-proofed MES and eBR solutions in regulated industries.
OCTOBER 17, 2024, BOSTON, MA — Tulip Interfaces, a leader in frontline operations, has announced the launch of its Composable MES App Suite for Pharmaceuticals. This suite includes a foundational set of downloadable apps and a common data model that brings intuitive, guided MES and eBR functionality to the frontlines of pharmaceutical operations. This suite, combined with new governance and validation features, transforms how regulated manufacturers can quickly and confidently digitize operations. By leveraging best practices distilled from partnerships with dozens of forward-thinking customers in the life sciences industry, Tulip brings a unique offering to an industry that has historically lacked access to such comprehensive, ready-to-configure tools.
With process agnostic templates, the Composable MES makes it easy for pharmaceutical manufacturers to implement digital solutions that accelerate batch release, ensure compliance, and improve quality – while showcasing what is possible with a small molecule-specific process example. The Composable MES includes app suites for electronic batch records, electronic logbooks, and batch production management – all built on an extensible common data model based on the digital twin concept: tables represent directly physical or operational artifacts.
Within the app suites, customers will benefit from pre-built app templates designed to meet the diverse operational needs of all manufacturers in regulated industries for seamless integration and deployment. These app templates serve as building blocks that companies can swiftly adapt, facilitating quicker implementation, reduced development costs, and enhanced operational agility. Each app is built on a qualified platform and can be validated for intended use ensuring manufacturers address the challenges of pharmaceutical operations while reducing the burden of validation and complying with regulatory frameworks and GxP requirements from the start.
“Our goal with the Composable MES App Suite for Pharmaceuticals is to empower manufacturers with the most flexible and powerful tools available today. By providing a platform that combines deep industry expertise with the latest digital innovations, we enable life sciences companies to streamline their operations, maintain compliance smoothly, and unlock new levels of operational efficiency. This is the future of manufacturing—agile, validated, and human-centric.” said Roey Mechrez, Head of Ecosystem at Tulip Interfaces.
Tulip is leading the way for integrated validation with a qualified platform and governed app development at scale. With their latest release, LTS 13, Tulip has introduced features to further reduce the burden of validation and change management, including seamless documentation between app versions, gated releases for apps, and governing user groups for controlled workflows.
With Tulip’s cloud-based platform, customers can take advantage of cutting-edge technology sooner. Available with LTS 13, the new Frontline Copilot™ is a collection of validatable AI features that allows app builders to create custom chats for troubleshooting, translate text, and generate insights from data, enhancing efficiency and decision-making.
Hundreds of manufacturers in life sciences have transformed their operations by integrating documentation and verification into workflows, dramatically reducing deviations, resolving non-conformances faster, and streamlining compliance processes. Pharmaceutical customers have reported a 75% reduction in time spent reviewing detailed logbooks and 30% faster processes with digital guidance and audit trails.
The Composable MES for Pharma suite is available to add to any customer Tulip instance within the Regulated Industries subscription tier and the new features are available with the latest version of Tulip, LTS 13.
ABOUT TULIP INTERFACES
Tulip, a leader in frontline operations, is helping companies of all sizes and across industries, including complex manufacturing, pharmaceuticals, and medical devices, equip their workforce with connected apps — leading to higher quality work, improved efficiency, and end-to-end traceability across operations. A spinoff out of MIT, the company is headquartered in Somerville, MA, with offices in Germany and Hungary.
Press contact: press@tulip.co